Century Therapeutics (IPSC) Operating Margin (2022 - 2025)
Century Therapeutics' (IPSC) quarterly Operating Margin came in at 67.95% in Q1 2025, up 372982.0% year-on-year from N/an in Q1 2024, and up 107.61% on a QoQ basis from 893.46% in Q4 2024.
Century Therapeutics (IPSC) Operating Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Operating Margin data on file, last reported at 67.95% in Q1 2025.
- On a quarterly basis, Operating Margin rose 372982.0% year-over-year to 67.95% in Q1 2025; TTM through Dec 2025 was 15.81%, a 208035.0% increase from a year earlier, with the FY2025 full-year figure at 15.82%, up 208066.0% from the prior year.
- Operating Margin for Q1 2025 stood at 67.95%, up from 893.46% in the prior quarter.
- Over the last five years, Operating Margin for IPSC reached as high as 67.95% in Q1 2025 and fell as low as 35431.31% in Q2 2023.
- Historically, Operating Margin has averaged 8053.42% across 4 years, with a median of 3661.87% in 2024.
- Across the five-year window, Operating Margin tumbled 3318554 bps in 2023 and jumped 3092353 bps in 2024, its largest moves.
- Year by year, Operating Margin stood at 6392.71% in 2022, then slumped by 155 bps to 16329.1% in 2023, then soared by 95 bps to 893.46% in 2024, then surged by 108 bps to 67.95% in 2025.
- Per Business Quant data, the three most recent Operating Margin figures were 67.95% in Q1 2025, 893.46% in Q4 2024, and 4398.1% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 67.95% |
| Dec 31, 2024 | -893.46% |
| Sep 30, 2024 | -4,398.10% |
| Jun 30, 2024 | -4,507.78% |
| Mar 31, 2024 | -3,661.87% |
| Dec 31, 2023 | -16,329.10% |
| Sep 30, 2023 | -24,071.62% |
| Jun 30, 2023 | -35,431.31% |
| Mar 31, 2023 | -1,865.17% |
| Dec 31, 2022 | -6,392.71% |
| Sep 30, 2022 | -1,427.07% |
| Jun 30, 2022 | -2,245.77% |
| Mar 31, 2022 | -3,538.37% |